NFGH
CABA icon

Nan Fung Group Holdings’s Cabaletta Bio CABA Stock Holding History

Nan Fung Group Holdings’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-47,150
Closed -$353K – 42
2024
Q2 		$353K Hold
47,150
– – 0.38% 28
2024
Q1 		$804K Hold
47,150
– – 0.75% 27
2023
Q4 		$1.07M Hold
47,150
– – 0.67% 22
2023
Q3 		$718K Buy
47,150
+6,027
+15% +$82.4K 0.58% 22
2023
Q2 		$531K Buy
+41,123
New +$446K 0.34% 30

Other funds holding CABA

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Nan Fung Group Holdings's CABA Position: Q3 2024 in Review

Nan Fung Group Holdings sold out of Cabaletta Bio (CABA) in Q3 2024, closing a stake of 47,150 shares — an estimated $353K sold.

Nan Fung Group Holdings first reported a position in CABA in Q2 2023 and held it in 5 quarters. The position peaked at $1.07M in Q4 2023. 120 funds tracked by Wall St. Rank hold CABA as of Q3 2024.

  • Nan Fung Group Holdings reported no remaining Cabaletta Bio position as of Q3 2024 after selling out during the quarter.
  • Nan Fung Group Holdings sold 47,150 Cabaletta Bio shares in Q3 2024, an estimated $353K.
  • Nan Fung Group Holdings first reported a position in Cabaletta Bio in Q2 2023 and held it in 5 quarters.
  • Nan Fung Group Holdings's Cabaletta Bio position peaked at $1.07M in Q4 2023.
  • 120 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2024.

Based on Nan Fung Group Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.